• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过功能定义的不同类别增强子重编程转录,这些增强子由 eRNA 定义。

Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.

机构信息

Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0651, USA.

出版信息

Nature. 2011 May 15;474(7351):390-4. doi: 10.1038/nature10006.

DOI:10.1038/nature10006
PMID:21572438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3117022/
Abstract

Mammalian genomes are populated with thousands of transcriptional enhancers that orchestrate cell-type-specific gene expression programs, but how those enhancers are exploited to institute alternative, signal-dependent transcriptional responses remains poorly understood. Here we present evidence that cell-lineage-specific factors, such as FoxA1, can simultaneously facilitate and restrict key regulated transcription factors, exemplified by the androgen receptor (AR), to act on structurally and functionally distinct classes of enhancer. Consequently, FoxA1 downregulation, an unfavourable prognostic sign in certain advanced prostate tumours, triggers dramatic reprogramming of the hormonal response by causing a massive switch in AR binding to a distinct cohort of pre-established enhancers. These enhancers are functional, as evidenced by the production of enhancer-templated non-coding RNA (eRNA) based on global nuclear run-on sequencing (GRO-seq) analysis, with a unique class apparently requiring no nucleosome remodelling to induce specific enhancer-promoter looping and gene activation. GRO-seq data also suggest that liganded AR induces both transcription initiation and elongation. Together, these findings reveal a large repository of active enhancers that can be dynamically tuned to elicit alternative gene expression programs, which may underlie many sequential gene expression events in development, cell differentiation and disease progression.

摘要

哺乳动物基因组中充斥着数以千计的转录增强子,它们协调着细胞类型特异性的基因表达程序,但这些增强子如何被利用来建立替代的、信号依赖性的转录反应仍知之甚少。在这里,我们提供的证据表明,细胞谱系特异性因子,如 FoxA1,可以同时促进和限制关键的调节转录因子,雄激素受体 (AR) 就是一个很好的例子,它可以作用于结构和功能上不同类别的增强子。因此,FoxA1 的下调是某些晚期前列腺肿瘤中不利的预后标志,它通过导致 AR 结合到一组截然不同的预先建立的增强子,引起激素反应的剧烈重编程,从而触发了大量的重编程。这些增强子是有功能的,这可以从基于全局核运行测序 (GRO-seq) 分析的增强子模板非编码 RNA (eRNA) 的产生中得到证明,其中一个独特的类别显然不需要核小体重塑来诱导特定的增强子-启动子环和基因激活。GRO-seq 数据还表明,配体结合的 AR 诱导转录起始和延伸。这些发现共同揭示了一个巨大的活跃增强子库,可以动态调节以引发替代的基因表达程序,这可能是发育、细胞分化和疾病进展中许多连续基因表达事件的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/a0b3808ae6c9/nihms-280996-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/ffbd7b0d7849/nihms-280996-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/92bb35b68f49/nihms-280996-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/9a191a491027/nihms-280996-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/a0b3808ae6c9/nihms-280996-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/ffbd7b0d7849/nihms-280996-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/92bb35b68f49/nihms-280996-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/9a191a491027/nihms-280996-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68c5/3117022/a0b3808ae6c9/nihms-280996-f0004.jpg

相似文献

1
Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.通过功能定义的不同类别增强子重编程转录,这些增强子由 eRNA 定义。
Nature. 2011 May 15;474(7351):390-4. doi: 10.1038/nature10006.
2
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer.FOXA2 重新为前列腺癌中的转录重编程和谱系可塑性构建了 AP-1。
Nat Commun. 2024 Jun 8;15(1):4914. doi: 10.1038/s41467-024-49234-9.
3
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.达罗他胺通过阻断增强子和超级增强子的激活来拮抗雄激素信号。
Mol Oncol. 2020 Sep;14(9):2022-2039. doi: 10.1002/1878-0261.12693. Epub 2020 Jun 5.
4
Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.增强子 RNA 参与雄激素受体驱动的环化,从而选择性地增强基因激活。
Proc Natl Acad Sci U S A. 2014 May 20;111(20):7319-24. doi: 10.1073/pnas.1324151111. Epub 2014 Apr 28.
5
LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.长链非编码 RNA DSCAM-AS1 通过与 YBX1 相互作用形成正反馈环,激活 FOXA1 转录网络,从而促进癌症进展。
Theranostics. 2020 Aug 29;10(23):10823-10837. doi: 10.7150/thno.47830. eCollection 2020.
6
FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.在去势抵抗性前列腺癌模型中,FOXA1调节雄激素受体变体活性。
Oncotarget. 2015 Oct 6;6(30):29782-94. doi: 10.18632/oncotarget.4927.
7
Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.雄激素受体增强子在前列腺癌细胞中无配体时的动态核小体缺失区域。
Mol Cell Biol. 2011 Dec;31(23):4648-62. doi: 10.1128/MCB.05934-11. Epub 2011 Oct 3.
8
Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.先驱因子GATA2在促进前列腺癌雄激素依赖性基因表达中的三重作用。
Nucleic Acids Res. 2014 Apr;42(6):3607-22. doi: 10.1093/nar/gkt1382. Epub 2014 Jan 13.
9
Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.全球分析去势抵抗性前列腺癌细胞中的转录,揭示了活跃的增强子和直接雄激素受体靶标。
Sci Rep. 2016 Sep 19;6:33510. doi: 10.1038/srep33510.
10
Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.共调节因子募集与雄激素受体在转录调控中的组蛋白修饰
Mol Endocrinol. 2004 Nov;18(11):2633-48. doi: 10.1210/me.2004-0245. Epub 2004 Aug 12.

引用本文的文献

1
Endogenous Real Time Imaging Reveals Dynamic Chromosomal Mobility During Ligand-Mediated Transcriptional Burst Events.内源性实时成像揭示配体介导的转录爆发事件期间染色体的动态移动性。
bioRxiv. 2025 Aug 19:2025.08.18.670875. doi: 10.1101/2025.08.18.670875.
2
Aberrant Enhancer Regulation, Phase Separation, and Autoimmune Diseases.异常增强子调控、相分离与自身免疫性疾病
Clin Rev Allergy Immunol. 2025 Aug 27;68(1):84. doi: 10.1007/s12016-025-09096-5.
3
Current progress and future perspective of super-enhancers: a viable and effective bridge between the transcriptional apparatus and disease.

本文引用的文献

1
FOXA1 is a key determinant of estrogen receptor function and endocrine response.FOXA1 是雌激素受体功能和内分泌反应的关键决定因素。
Nat Genet. 2011 Jan;43(1):27-33. doi: 10.1038/ng.730. Epub 2010 Dec 12.
2
Mediator and cohesin connect gene expression and chromatin architecture.中介体和黏合蛋白连接基因表达和染色质结构。
Nature. 2010 Sep 23;467(7314):430-5. doi: 10.1038/nature09380. Epub 2010 Aug 18.
3
Integrative genomic profiling of human prostate cancer.人类前列腺癌的综合基因组分析。
超级增强子的当前进展与未来展望:转录装置与疾病之间可行且有效的桥梁
Front Genet. 2025 Jul 2;16:1611905. doi: 10.3389/fgene.2025.1611905. eCollection 2025.
4
A Super Enhancer-Derived Enhancer RNA Acts Together with CTCF/Cohesin in Trans to Regulate Erythropoiesis.一种源自超级增强子的增强子RNA与CTCF/黏连蛋白协同作用,在反式作用中调节红细胞生成。
Genes (Basel). 2025 Mar 28;16(4):389. doi: 10.3390/genes16040389.
5
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review).长链非编码RNA在致癌作用中的表观遗传和表转录组学作用(综述)
Int J Oncol. 2025 Apr;66(4). doi: 10.3892/ijo.2025.5735. Epub 2025 Feb 28.
6
Early Detection of the Pathogenetic Variants of Homologous Recombination Repair Genes in Prostate Cancer: Critical Analysis and Experimental Design.前列腺癌中同源重组修复基因致病变异的早期检测:批判性分析与实验设计
Biology (Basel). 2025 Jan 23;14(2):117. doi: 10.3390/biology14020117.
7
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.前列腺癌异质性的种系和体细胞起源
Cancer Discov. 2025 May 2;15(5):988-1017. doi: 10.1158/2159-8290.CD-23-0882.
8
Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer.前列腺癌免疫冷微环境的肿瘤内在调节因子。
Trends Endocrinol Metab. 2025 Jan 2. doi: 10.1016/j.tem.2024.12.003.
9
Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome.在Wnt驱动的长链非编码转录组中识别结直肠癌特异性的脆弱点。
Gut. 2025 Mar 6;74(4):571-585. doi: 10.1136/gutjnl-2024-332752.
10
A guide to studying 3D genome structure and dynamics in the kidney.肾脏三维基因组结构与动力学研究指南。
Nat Rev Nephrol. 2025 Feb;21(2):97-114. doi: 10.1038/s41581-024-00894-2. Epub 2024 Oct 15.
Cancer Cell. 2010 Jul 13;18(1):11-22. doi: 10.1016/j.ccr.2010.05.026. Epub 2010 Jun 24.
4
Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.转录因子的简单组合为巨噬细胞和 B 细胞特性所需的顺式调控元件提供了启动条件。
Mol Cell. 2010 May 28;38(4):576-89. doi: 10.1016/j.molcel.2010.05.004.
5
Widespread transcription at neuronal activity-regulated enhancers.神经元活动调节增强子的广泛转录。
Nature. 2010 May 13;465(7295):182-7. doi: 10.1038/nature09033. Epub 2010 Apr 14.
6
Nucleosome dynamics define transcriptional enhancers.核小体动力学定义转录增强子。
Nat Genet. 2010 Apr;42(4):343-7. doi: 10.1038/ng.545. Epub 2010 Mar 7.
7
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.SOX9 在前列腺中的升高促进了细胞增殖,并与 PTEN 缺失协同作用驱动肿瘤形成。
Cancer Res. 2010 Feb 1;70(3):979-87. doi: 10.1158/0008-5472.CAN-09-2370. Epub 2010 Jan 26.
8
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.雄激素受体在雄激素非依赖性前列腺癌中调控着一个独特的转录程序。
Cell. 2009 Jul 23;138(2):245-56. doi: 10.1016/j.cell.2009.04.056.
9
Histone modifications at human enhancers reflect global cell-type-specific gene expression.人类增强子上的组蛋白修饰反映了整体细胞类型特异性基因表达。
Nature. 2009 May 7;459(7243):108-12. doi: 10.1038/nature07829. Epub 2009 Mar 18.
10
Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling.使用核糖体谱分析在体内以核苷酸分辨率进行全基因组翻译分析。
Science. 2009 Apr 10;324(5924):218-23. doi: 10.1126/science.1168978. Epub 2009 Feb 12.